Physician profile
Kenneth E Hamilton
NPI 1760462618
$4,089.89
in general payments reported to CMS, 2019-2025
35 companies · $530 in 2025
The $530 reported for 2025 was more than what 82% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $583 · 2020: $904 · 2021: $298 · 2022: $811 · 2023: $432 · 2024: $532 · 2025: $530.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,494.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,493.75 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Coloplast Corp | $772.81 | 2019-2025 | |
| Abbvie INC. | $529.57 | 2019-2023 | |
| Astellas Pharma US INC | $365.26 | 2019-2025 | Veozah |
| Organon LLC | $226.20 | 2021-2025 | Nexplanon |
| Pfizer INC. | $218.71 | 2019-2024 | |
| Gynesonics, INC. | $216.62 | 2022 | |
| Mayne Pharma Commercial LLC | $173.90 | 2025 | |
| Hologic Sales and Service, LLC | $157.03 | 2020-2025 | Omni Hysteroscope, Fluent Fluid Management System, Novasure |
| Coopersurgical, INC. | $147.96 | 2020-2024 | Endosee |
| Therapeuticsmd, INC. | $142.61 | 2019-2022 | |
| Sumitomo Pharma America, INC. | $142.01 | 2023-2025 | Myfembree |
| Intuitive Surgical, INC. | $138.48 | 2022-2024 | |
| Myovant Sciences INC. | $97.13 | 2021-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $84.50 | 2022-2023 | |
| Exeltis, USA INC. | $78.31 | 2019-2025 | Slynd |
Show all 35 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Roche Diagnostics Corporation | $78.25 | 2019 | |
| Amag Pharmaceuticals, INC. | $65.52 | 2019 | |
| Sage Therapeutics, LLC | $47.93 | 2024-2025 | Zurzuvae |
| Meditrina | $45.08 | 2022-2025 | |
| Duchesnay USA Incorporated | $39.95 | 2019 | |
| Ethicon US, LLC | $39.84 | 2022-2025 | Stratafix, Vistaseal |
| Millicent US INC | $36.23 | 2024 | Intrarosa, Femring |
| Scynexis, INC. | $30.32 | 2022 | |
| Minerva Surgical, INC | $27.30 | 2019 | |
| Avion Pharmaceuticals | $26.80 | 2019-2020 | |
| Daiichi Sankyo INC. | $22.82 | 2023 | Injectafer |
| Pacira Pharmaceuticals Incorporated | $21.41 | 2019 | |
| Mylan Pharmaceuticals INC. | $19.07 | 2021 | |
| Solventum Corporation | $17.28 | 2024 | Ioban 2, Prevena |
| Supernus Pharmaceuticals, INC. | $16.31 | 2025 | Qelbree |
| Davol INC. | $15.75 | 2019 | |
| Acessa Health INC. | $12.81 | 2019 | |
| Mallinckrodt Enterprises LLC | $12.42 | 2019 | |
| Evofem Biosciences, INC. | $12.37 | 2021 | |
| Allergan, INC. | $11.33 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kenneth Hamilton listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.